Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
AB8939 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, GATA2 deficiency with susceptibility to MDS/AML, Hemic and Lymphatic Diseases, Myelodysplastic Syndrome Acute Myeloid Leukemia, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, hereditary disease, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasmRecruitingPhase 1 / Phase 22025-10-02NCT05211570

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AB Science5

10 results · Page 1 of 1